BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 8736077)

  • 1. A comparative study of risk factors for hyperplasia and cancer of the endometrium.
    Baanders-van Halewyn EA; Blankenstein MA; Thijssen JH; de Ridder CM; de Waard F
    Eur J Cancer Prev; 1996 Apr; 5(2):105-12. PubMed ID: 8736077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endometrial cancer in a cohort screened for breast cancer.
    de Waard F; de Ridder CM; Baanders-van Halewyn EA; Slotboom BJ
    Eur J Cancer Prev; 1996 Apr; 5(2):99-104. PubMed ID: 8736076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Body mass index trumps age in decision for endometrial biopsy: cohort study of symptomatic premenopausal women.
    Wise MR; Gill P; Lensen S; Thompson JM; Farquhar CM
    Am J Obstet Gynecol; 2016 Nov; 215(5):598.e1-598.e8. PubMed ID: 27287687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term outcome of postmenopausal women with proliferative endometrium on endometrial sampling.
    Rotenberg O; Doulaveris G; Fridman D; Renz M; Kaplan J; Xie X; Goldberg GL; Dar P
    Am J Obstet Gynecol; 2020 Dec; 223(6):896.e1-896.e7. PubMed ID: 32640199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of endometrial cancer and hyperplasia in non-symptomatic overweight and obese women.
    Viola AS; Gouveia D; Andrade L; Aldrighi JM; Viola CF; Bahamondes L
    Aust N Z J Obstet Gynaecol; 2008 Apr; 48(2):207-13. PubMed ID: 18366497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of the levonorgestrel intrauterine system (LNG-IUS) in the prevention of the atypical endometrial hyperplasia and endometrial cancer: retrospective data from selected obese menopausal symptomatic women.
    Morelli M; Di Cello A; Venturella R; Mocciaro R; D'Alessandro P; Zullo F
    Gynecol Endocrinol; 2013 Feb; 29(2):156-9. PubMed ID: 23134558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thickened endometrium in asymptomatic postmenopausal women - determining an optimum threshold for prediction of atypical hyperplasia and cancer.
    Ghoubara A; Emovon E; Sundar S; Ewies A
    J Obstet Gynaecol; 2018 Nov; 38(8):1146-1149. PubMed ID: 29862866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes in women age 40 years and older with cytologically benign endometrial cells.
    Casey PM; Gallenberg MM; Kastner TM; Barrette BA; Chantigian PD; Shuster LT; MacLaughlin KL; Allensworth SK; Weaver AL
    Am J Obstet Gynecol; 2012 Nov; 207(5):379.e1-6. PubMed ID: 22964067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oestrogens and endometrial hyperplasia.
    Thom MH; Studd JW
    Br J Hosp Med; 1980 May; 23(5):506, 508-9, 511-3. PubMed ID: 6992895
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Can ultrasound replace dilation and curettage? A longitudinal evaluation of postmenopausal bleeding and transvaginal sonographic measurement of the endometrium as predictors of endometrial cancer.
    Gull B; Karlsson B; Milsom I; Granberg S
    Am J Obstet Gynecol; 2003 Feb; 188(2):401-8. PubMed ID: 12592247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endometrial hyperplasia and endometrial cancer.
    Burke TW; Tortolero-Luna G; Malpica A; Baker VV; Whittaker L; Johnson E; Follen Mitchell M
    Obstet Gynecol Clin North Am; 1996 Jun; 23(2):411-56. PubMed ID: 8784886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Androgens in breast cancer. I. Atypical endometrial hyperplasia and breast cancer in married premenopausal women.
    Grattarola R
    Am J Obstet Gynecol; 1973 Jun; 116(3):423-8. PubMed ID: 4707544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endometrial cancer and hyperplasia rate in women before menopause with abnormal uterine bleeding undergoing endometrial sampling.
    Gawron I; Łoboda M; Babczyk D; Ludwin I; Basta P; Pityński K; Ludwin A
    Przegl Lek; 2017; 74(4):139-43.. PubMed ID: 29696944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The relationship between cigarette smoking and the risk of endometrial neoplasms.
    Weir HK; Sloan M; Kreiger N
    Int J Epidemiol; 1994 Apr; 23(2):261-6. PubMed ID: 8082951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patients with atypical hyperplasia of the endometrium should be treated in oncological centers.
    Antonsen SL; Ulrich L; Høgdall C
    Gynecol Oncol; 2012 Apr; 125(1):124-8. PubMed ID: 22198048
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of malignancy in endometrial polyps: study of 421 women with postmenopausal bleeding.
    Ghoubara A; Sundar S; Ewies AAA
    Climacteric; 2018 Feb; 21(1):82-87. PubMed ID: 29219004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prevalence of endometrial injury in asymptomatic obese women].
    Gouveia DA; Bahamondes L; Aldrighi JM; Tamanaha S; Ribeiro AL; Aoki T
    Rev Assoc Med Bras (1992); 2007; 53(4):344-8. PubMed ID: 17823739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors for adenomatous endometrial hyperplasia: a case-control study.
    Kreiger N; Marrett LD; Clarke EA; Hilditch S; Woolever CA
    Am J Epidemiol; 1986 Feb; 123(2):291-301. PubMed ID: 3946378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Case-control study of endogenous steroid hormones and endometrial cancer.
    Potischman N; Hoover RN; Brinton LA; Siiteri P; Dorgan JF; Swanson CA; Berman ML; Mortel R; Twiggs LB; Barrett RJ; Wilbanks GD; Persky V; Lurain JR
    J Natl Cancer Inst; 1996 Aug; 88(16):1127-35. PubMed ID: 8757192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening by ultrasonography for endometrial carcinoma in postmenopausal breast cancer patients under adjuvant tamoxifen.
    Cecchini S; Ciatto S; Bonardi R; Mazzotta A; Grazzini G; Pacini P; Muraca MG
    Gynecol Oncol; 1996 Mar; 60(3):409-11. PubMed ID: 8774648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.